Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

INOMAX DSIR (DELIVERY SYSTEM)

K-Number: K130605 · 2013-05-02

ApplicantIno Therapeutics
Decision Date2013-05-02
Product CodeMRN
Advisory CommitteeAN
DecisionSubstantially Equivalent

Device Summary

INOMAX DSIR (DELIVERY SYSTEM) is the device name listed in this FDA 510(k) record. The listed applicant is Ino Therapeutics. It received FDA 510(k) clearance on 2013-05-02 under 510(k) number K130605. The device is classified under product code MRN. It was reviewed by the AN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the INOMAX DSIR (DELIVERY SYSTEM)?

INOMAX DSIR (DELIVERY SYSTEM) is a medical device that received FDA 510(k) clearance on 2013-05-02. The listed applicant is Ino Therapeutics. The 510(k) number is K130605.

When did INOMAX DSIR (DELIVERY SYSTEM) receive FDA 510(k) clearance?

INOMAX DSIR (DELIVERY SYSTEM) received FDA 510(k) clearance on 2013-05-02, under 510(k) number K130605.

Who is the listed applicant for INOMAX DSIR (DELIVERY SYSTEM)?

The FDA 510(k) record lists Ino Therapeutics as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for INOMAX DSIR (DELIVERY SYSTEM)?

The FDA product code for INOMAX DSIR (DELIVERY SYSTEM) is MRN.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Ino Therapeutics as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K122689INOBLENDERK121021INOMAX DS (DELIVERY SYSTEM)K110344INOMAX DSIR (DELIVERY SYSTEM)K093922INOMAX DSK080484INOMAX DS (DELIVERY SYSTEM), MODEL 10003K061901INO THERAPEUTICS INOMAX DS (DELIVERY SYSTEM), MODEL 10003

View all 8 devices →

Related Devices (Code: MRN)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K242374ULSPIRA TS™ Nitric Oxide Therapy SystemAirgas Therapeutics, LLCK242578EVOLVE Nitric Oxide Delivery SystemMallinckrodt Manufacturing, LLCK240410EVOLVE Nitric Oxide Delivery SystemMalinckrodt Manufacturing, LLCK233251NOxBOXi Nitric Oxide Delivery SystemLinde Gas & Equipment, Inc.K222930Evolve Nitric Oxide Delivery SystemMallinckrodt Manufacturing, LLCK231823NOxBOXi Nitric Oxide Delivery SystemLinde Gas & Equipment, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑